{"text": ["Bristol-Myers Squibb and AbbVie Receive FDA Approval of Empliciti\u2122 (elotuzumab) for the Treatment of Patients with Multiple Myeloma Who Have Received One to Three Prior Therapies"], "created_at": "Mon, 30 Nov 2015 08:00:00 GMT"}
